PD-L1 chimeric costimulatory receptor improves the efficacy of CAR-T cells for PD-L1-positive solid tumors and reduces toxicity in vivo

Overview of attention for article published in Biomarker Research, November 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (71st percentile)
Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 25 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

GENETIC ENGINEERING MODIFIED DUAL-TARGET CHIMERIC ANTIGEN RECEPTOR AND USE THEREOF

Application EP-3950718-A4

European Patent Office

GENETICALLY MODIFIED T CELLS AND USES THEREOF

Application WO-2021071431-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.